Residential surrounding greenspace and age at menopause: A 20-year European study (ECRHS).


Journal

Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270

Informations de publication

Date de publication:
11 2019
Historique:
received: 04 04 2019
revised: 18 07 2019
accepted: 08 08 2019
pubmed: 23 8 2019
medline: 26 2 2020
entrez: 23 8 2019
Statut: ppublish

Résumé

Menopause is associated with a number of adverse health effects and its timing has been reported to be influenced by several lifestyle factors. Whether greenspace exposure is associated with age at menopause has not yet been investigated. To investigate whether residential surrounding greenspace is associated with age at menopause and thus reproductive aging. This longitudinal study was based on the 20-year follow-up of 1955 aging women from a large, population-based European cohort (ECRHS). Residential surrounding greenspace was abstracted as the average of satellite-based Normalized Difference Vegetation Index (NDVI) across a circular buffer of 300 m around the residential addresses of each participant during the course of the study. We applied mixed effects Cox models with centre as random effect, menopause as the survival object, age as time indicator and residential surrounding greenspace as time-varying predictor. All models were adjusted for smoking habit, body mass index, parity, age at menarche, ever-use of contraception and age at completed full-time education as socio-economic proxy. An increase of one interquartile range of residential surrounding greenspace was associated with a 13% lower risk of being menopausal (Hazard Ratio: 0.87, 95% Confidence Interval: 0.79-0.95). Correspondingly the predicted median age at menopause was 1.4 years older in the highest compared to the lowest NDVI quartile. Results remained stable after additional adjustment for air pollution and traffic related noise amongst others. Living in greener neighbourhoods is associated with older age at menopause and might slow reproductive aging. These are novel findings with broad implications. Further studies are needed to see whether our findings can be replicated in different populations and to explore the potential mechanisms underlying this association.

Sections du résumé

BACKGROUND
Menopause is associated with a number of adverse health effects and its timing has been reported to be influenced by several lifestyle factors. Whether greenspace exposure is associated with age at menopause has not yet been investigated.
OBJECTIVE
To investigate whether residential surrounding greenspace is associated with age at menopause and thus reproductive aging.
METHODS
This longitudinal study was based on the 20-year follow-up of 1955 aging women from a large, population-based European cohort (ECRHS). Residential surrounding greenspace was abstracted as the average of satellite-based Normalized Difference Vegetation Index (NDVI) across a circular buffer of 300 m around the residential addresses of each participant during the course of the study. We applied mixed effects Cox models with centre as random effect, menopause as the survival object, age as time indicator and residential surrounding greenspace as time-varying predictor. All models were adjusted for smoking habit, body mass index, parity, age at menarche, ever-use of contraception and age at completed full-time education as socio-economic proxy.
RESULTS
An increase of one interquartile range of residential surrounding greenspace was associated with a 13% lower risk of being menopausal (Hazard Ratio: 0.87, 95% Confidence Interval: 0.79-0.95). Correspondingly the predicted median age at menopause was 1.4 years older in the highest compared to the lowest NDVI quartile. Results remained stable after additional adjustment for air pollution and traffic related noise amongst others.
CONCLUSIONS
Living in greener neighbourhoods is associated with older age at menopause and might slow reproductive aging. These are novel findings with broad implications. Further studies are needed to see whether our findings can be replicated in different populations and to explore the potential mechanisms underlying this association.

Identifiants

pubmed: 31437647
pii: S0160-4120(19)31129-8
doi: 10.1016/j.envint.2019.105088
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105088

Subventions

Organisme : Medical Research Council
ID : G0901214
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Kai Triebner (K)

Department of Clinical Science, University of Bergen, Bergen, Norway; Core Facility for Metabolomics, University of Bergen, Bergen, Norway. Electronic address: kai.triebner@uib.no.

Iana Markevych (I)

Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany; Institute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.

Steinar Hustad (S)

Department of Clinical Science, University of Bergen, Bergen, Norway; Core Facility for Metabolomics, University of Bergen, Bergen, Norway.

Bryndís Benediktsdóttir (B)

Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Bertil Forsberg (B)

Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Karl A Franklin (KA)

Department of Surgical and Perioperative Sciences, Surgery, Umea University, Umea, Sweden.

José Antonio Gullón Blanco (JA)

Pneumology Department, University Hospital San Agustín, Avilés, Spain.

Mathias Holm (M)

Department of Occupational and Environmental Medicine, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.

Bénédicte Jaquemin (B)

Barcelona Institute for Global Health, Barcelona, Spain.

Debbie Jarvis (D)

National Heart and Lung Institute, Imperial College, London, United Kingdom.

Rain Jõgi (R)

Tartu University Hospital, Lung Clinic, Estonia.

Bénédicte Leynaert (B)

INSERM UMR1152, Paris, France; INSERM U1168, VIMA, Villejuif, France.

Eva Lindberg (E)

Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.

Jesús Martínez-Moratalla (J)

Pulmonology Service, Albacete University Hospital Complex, Health Service of Castilla - La Mancha, Albacete, Spain; Faculty of Medicine of Albacete, Castilla-La Mancha University, Albacete, Spain.

Nerea Muniozguren Agirre (N)

Unit of Epidemiology and Public Health, Department of Health, Basque Government, Bilbao, Spain.

Isabelle Pin (I)

Department of Pediatrics, CHU Grenoble Alpes, Grenoble, France; INSERM, Institute for Advanced Biosciences, Grenoble, France; Université Grenoble Alpes, Grenoble, France.

José Luis Sánchez-Ramos (JL)

Department of Nursing, University of Huelva, Huelva, Spain.

Joachim Heinrich (J)

Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany; Allergy and Lung Health Unit, Melbourne School of Population and Global Health, University of Melbourne, Carlton, Australia.

Francisco Gómez Real (F)

Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.

Payam Dadvand (P)

Barcelona Institute for Global Health, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH